Neonc Technologies Holdings (NTHI) Research & Development (2024 - 2026)
Neonc Technologies Holdings (NTHI) posted quarterly Research & Development of $1.3 million for Q1 2026, up 28.86% year-over-year from $998222.0 in Q1 2025, and up 3.1% quarter-over-quarter from $1.2 million in Q4 2025.
Neonc Technologies Holdings (NTHI) Research & Development (2024 - 2026) Analysis & Trends
Neonc Technologies Holdings (NTHI) has reported Research & Development for 3 consecutive years, with $1.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Research & Development rose 28.86% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $3.9 million (up 14.51% YoY), while the FY2025 annual figure was $3.6 million, up 19.47% from the prior year.
- Research & Development climbed to $1.3 million in Q1 2026 per NTHI's latest filing, from $1.2 million in the prior quarter.
- Across five years, Research & Development topped out at $1.3 million in Q1 2026 and bottomed at $394484.0 in Q2 2024.
- Historically, Research & Development has averaged $885536.9 across 3 years, with a median of $956725.0 in 2024.
- On a YoY basis, Research & Development climbed as much as 71.7% in 2025 and fell as far as 25.26% in 2025.
- Neonc Technologies Holdings' Research & Development stood at $1.1 million in 2024, then climbed by 15.58% to $1.2 million in 2025, then gained by 3.1% to $1.3 million in 2026.
- Business Quant data shows NTHI's Research & Development at $1.3 million in Q1 2026, $1.2 million in Q4 2025, and $715038.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 993.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.63 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 651.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 612.28 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 413.13 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -588.31 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 210.03 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 97.90 Mn |
| 10 | Neonc Technologies Holdings | 116.41 Mn | 116.41 Mn | - | 2.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.65 Mn |
| Mar 31, 2026 | 1.29 Mn |
| Dec 31, 2025 | 1.25 Mn |
| Sep 30, 2025 | 715,038.00 |
| Jun 30, 2025 | 677,332.00 |
| Mar 31, 2025 | 998,222.00 |
| Dec 31, 2024 | 1.08 Mn |
| Sep 30, 2024 | 956,725.00 |
| Jun 30, 2024 | 394,484.00 |
| Mar 31, 2024 | 614,517.00 |